Serum CCL23 as a Potential Biomarker for Asthma in Pregnancy: A Prospective Case-Control Study
Journal of Asthma and Allergy · 2026-11 · Volume 19 · 1-18
DOI: 10.2147/jaa.s644651 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Journal of Asthma and Allergy, 2026-11. Verfasst von Jing Xie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu S…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, People's Republic…
- Department of Obstetrics, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, People's Republic of China.
Zitieren
APA
Xie, J., Yan, X., Song, Y., Wang, H., Xu, G., & Xu, L. (2026). Serum CCL23 as a Potential Biomarker for Asthma in Pregnancy: A Prospective Case-Control Study. Journal of Asthma and Allergy, Volume 19, 1-18. https://doi.org/10.2147/jaa.s644651
Vancouver
Xie J, Yan X, Song Y, Wang H, Xu G, Xu L. Serum CCL23 as a Potential Biomarker for Asthma in Pregnancy: A Prospective Case-Control Study. Journal of Asthma and Allergy. 2026;Volume 19:1-18. doi:10.2147/jaa.s644651
BibTeX
@article{Xie2026,
author = {Xie, Jing and Yan, Xiaopei and Song, Ye and Wang, Hui and Xu, Guopeng and Xu, Li},
title = {Serum CCL23 as a Potential Biomarker for Asthma in Pregnancy: A Prospective Case-Control Study},
journal = {Journal of Asthma and Allergy},
year = {2026},
volume = {Volume 19},
pages = {1--18},
doi = {10.2147/jaa.s644651}
}
EUVIMED